Search -

Displaying 1 - 6 of 6

Sort: Relevancy | Date

Tenecteplase Feasible Up to 24 Hours After Stroke

News Conference News ISC 2022

Tenecteplase Feasible Up to 24 Hours After Stroke

February 15, 2022

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

November 15, 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

June 21, 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

May 23, 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

April 28, 2018

News Conference News ACC 2016

Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding

April 06, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.